Paper18508317
Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival.
Shono T and 14 others. Int J Cancer, 2008. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. Papers, record 18508317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18508317
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioma | Major topic |
| NADPH Oxidases | Major topic |
| Apoptosis | |
| Astrocytoma | |
| Cell Growth Processes | |
| Cell Line, Tumor | |
| Cells, Cultured | |
| Endothelial Cells | |
| Gene Expression | |
| Humans | |
| Immunohistochemistry | |
| NADPH Oxidase 4 | |
| RNA Interference | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Transfection |
Source PubMed
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41862812 | Targeting dormant cancer cells: ferroptosis as a precision therapeutic strategy. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/41862812 | PubMed |
| 40867242 | Explainable Machine Learning Models for Glioma Subtype Classification and Survival Prediction. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40867242 | PubMed |
| 40266050 | NOX Family: Regulators of Reactive Oxygen Species Balance in Tumor Cells. | FASEB J | 2025 | https://conductscience.org/library/papers/40266050 | PubMed |
| 39814410 | NADPH oxidases: redox regulation of cell homeostasis and disease. | Physiol Rev | 2025 | https://conductscience.org/library/papers/39814410 | PubMed |
| 39727012 | CYBC1 Drives Glioblastoma Progression via Reactive Oxygen Species and NF-κB Pathways. | Cancer Res Treat | 2025 | https://conductscience.org/library/papers/39727012 | PubMed |
| 37650225 | NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors. | J Med Chem | 2023 | https://conductscience.org/library/papers/37650225 | PubMed |
| 37643785 | CYBA as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis. | Cancer Genomics Proteomics | 2023 | https://conductscience.org/library/papers/37643785 | PubMed |
| 37321060 | Nox4 as a novel therapeutic target for diabetic vascular complications. | Redox Biol | 2023 | https://conductscience.org/library/papers/37321060 | PubMed |
| 36768405 | NOX Dependent ROS Generation and Cell Metabolism. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768405 | PubMed |
| 36169772 | Exploring the role of Nrf2 signaling in glioblastoma multiforme. | Discov Oncol | 2022 | https://conductscience.org/library/papers/36169772 | PubMed |
| 35938505 | A novobiocin derivative, XN4, triggers ferroptosis in gastric cancer cells via the activation of NOX4. | Pharm Biol | 2022 | https://conductscience.org/library/papers/35938505 | PubMed |
| 35935861 | Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35935861 | PubMed |
| 35646942 | NADPH Oxidase 4: A Potential Therapeutic Target of Malignancy. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35646942 | PubMed |
| 35528617 | Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA. | J Immunol Res | 2022 | https://conductscience.org/library/papers/35528617 | PubMed |
| 35269843 | NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269843 | PubMed |
| 35203105 | NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells. | Mol Oncol | 2022 | https://conductscience.org/library/papers/35203105 | PubMed |
| 34740322 | NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34740322 | PubMed |
| 34257808 | NOX4-Derived ROS Mediates TGF-β1-Induced Metabolic Reprogramming during Epithelial-Mesenchymal Transition through the PI3K/AKT/HIF-1α Pathway in Glioblastoma. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34257808 | PubMed |
| 34112960 | ATF3 contributes to brucine-triggered glioma cell ferroptosis via promotion of hydrogen peroxide and iron. | Acta Pharmacol Sin | 2021 | https://conductscience.org/library/papers/34112960 | PubMed |
| 33392923 | G protein-coupled receptor kinase 2 modifies the cellular reaction to cisplatin through interactions with NADPH oxidase 4. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/33392923 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NOX4 | 50507 | PubTator's text mining | https://conductscience.org/library/genes/50507 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18508317
GET https://conductscience.org/api/papers/v1/18508317/cited_by?page=2